Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45
QIAGEN NV
QIAGEN NV QGEN | 0.00 |
Citigroup analyst Brendan Digan maintains Qiagen (NYSE:
QGEN) with a Neutral and raises the price target from $38 to $45.
Citigroup Maintains Neutral on Qiagen, Raises Price Target to $45
QIAGEN NV QGEN | 0.00 |